The protective effects of trimetazidine against ovary ischemia–reperfusion injury via the TLR4/Nf‐kB signal pathway
article
OA: closed
CC0
Abstract
Late diagnosis and treatment of ovarian ischemia can lead to worsening of ischemia, irreversible damage to ovarian functions and infertility. In this process, there is no approved medical treatment that can reduce the negative effects of ischemia and contribute positively to ovarian functions during reperfusion after detorsion. Rats were randomly assigned into one of six groups of eight animals each. The groups were designed as follows: The control group, The ischemia(I) group, The Ischemia + Trimetazidine (I + TMZ) (20 mg/kg) group, and The ischemia-reperfusion group (I/R). The Ischemia-Reperfusion + Trimetazidine (I/R + TMZ) (20 mg/kg) group, and The Sham + Trimetazidine (Sham + TMZ) (20 mg/kg) group. In this study performed thiobarbituric acid reactive substances (TBARS), total thiol (-SH), interleukin 1 beta (IL-1β), interleukin 6 (IL-6), toll-like receptor 4 (TLR4), and nuclear factor-kappa B(NF-κβ). Increased oxidative stress and inflammation were as a result of ovarian I and I/R application. Trimetazidine (TMZ), was sufficient to reduce the oxidative stress and inflammation. TLR4 and NF-κβ, which were upregulated by oxidative stress and inflammation, were regressed by TMZ. TMZ should be considered as a potential therapeutic agent in addition to surgery in the clinical treatment of ovarian torsion.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (44)
- W976552259 via openalex
- W1613011747 via openalex
- W1966859768 via openalex
- W1974048083 via openalex
- W1983310681 via openalex
- W1983437179 via openalex
- W1991385182 via openalex
- W2001685010 via openalex
- W2008870586 via openalex
- W2014534188 via openalex
- W2016417634 via openalex
- W2049926497 via openalex
- W2061506775 via openalex
- W2087585138 via openalex
- W2110366206 via openalex
- W2124105006 via openalex
- W2159590314 via openalex
- W2163050654 via openalex
- W2179410813 via openalex
- W2291930941 via openalex
- W2555006756 via openalex
- W2562070726 via openalex
- W2588844111 via openalex
- W2728235462 via openalex
- W2729867100 via openalex
- W2740695644 via openalex
- W2769010008 via openalex
- W2783181755 via openalex
- W2794076345 via openalex
- W2810030038 via openalex
- W2810239386 via openalex
- W2891099970 via openalex
- W2900793334 via openalex
- W2914715888 via openalex
- W2919756826 via openalex
- W2988374337 via openalex
- W2990337693 via openalex
- W3081960618 via openalex
- W3114641088 via openalex
- W3122717651 via openalex
- W3123712959 via openalex
- W3128752583 via openalex
- W3131323624 via openalex
- W4238380548 via openalex
SciLite annotations
chemicals 7
amlodipine benzenesulfonate
amlodipine benzenesulfonate
amlodipine benzenesulfonate
amlodipine benzenesulfonate
barbituric acid
thiol
amlodipine benzenesulfonate
organisms 2
rattus sp.
multicellular animals
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- scilite
- last seen: 2026-05-18T04:26:01.642840+00:00
- unpaywall
- last seen: 2026-06-19T06:35:33.578913+00:00
License: CC0
· commercial use OK